Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $4.31 on revenue of $2.79B. Analysts polled by Investing.com anticipated EPS of $3.71 on revenue of $2.73B.
Quest Diagnostics shares are up 15% from the beginning of the year and are trading at $122.83 , down-from-52-week-high.They are outperforming the S&P 500 which is up 6.34% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Abbott Labs had beat expectations on Wednesday with third quarter EPS of $0.98 on revenue of $8.85B, compared to forecast for EPS of $0.9 on revenue of $8.5B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar